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Receptors for the Fc domain of IgG (Fc receptors [FcR] 1)  have been found on a 
variety of macrophage and  lymphoid cell types  (1).  FcR  activity of mouse macro- 
phages  has  been  the  most  extensively studied,  and  current  evidence  indicates  the 
presence  of  two  distinct  receptors.  Based  on  quantitative  binding  data,  several 
laboratories have concluded that both IgGl and IgG2b bind to a trypsin-resistant site, 
whereas IgG2a binding is sensitive to prior trypsinization  (2-7).  In addition,  aggre- 
gated  IgG2b was  found  not  to inhibit  the binding of IgG2a, and  vice versa  (2-4). 
Further  support  for  the  two-receptor  hypothesis  comes  from the  analysis  of FcR- 
negative derivatives of the macrophage-like cell line J774. Although the variant clones 
were almost totally deficient in the ability to bind IgG2b, they bound IgG2a normally 
(8). 
Recently, we reported the isolation of a  monoclonal rat anti-mouse FcR antibody 
that  appears to be specifically directed  against  the trypsin-resistant  IgG2b receptor 
(9).  The  Fab  fragment  of this  antibody,  designated  2.4(32  IgG,  inhibited  rosette 
formation by IgG1- and  IgG2b-sensitized sheep  erythrocytes  (E)  on  mouse  macro- 
phages, neutrophils,  and spleen cells as well as on mouse FcR-bearing cell  lines of 
macrophage, B, T, and null  lymphocyte origin.  Rosette formation by IgG2a-coated 
E, on the other hand, was unaffected. Moreover, 125I-2.4G2 Fab bound only to FcR- 
bearing cell types, and the binding of 2.4(32 to macrophages was unaffected by prior 
trypsinization of the cells. 
It is clear that  the further characterization  of FcR activity requires  the isolation 
and analysis of the receptor molecule(s). Accordingly, there have been a  number of 
reports of the partial purification of FcR from both mOuse and human macrophages 
and lymphocytes. Most  of these studies  have employed techniques of affinity chro- 
matography with  IgG immobilized on a  solid  support  to  isolate proteins  from cell 
iysates. However, no consensus has emerged regarding even such a basic characteristic 
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as the apparent  molecular weight  (Mr)  of the molecule, with estimates ranging from 
20,000 to 255,000 (10-18). 
In this study, we have employed the anti-FcR antibody 2.4G2 as an affinity reagent 
to accomplish the one-step purification of the receptor to apparent homogeneity from 
the mouse macrophage cell line J774.  100-#g quantities  of the receptor glycoprotein 
were isolated  and characterized  biochemically.  The purified  material  retained  FcR 
activity in vitro, and the subclass specificity of the isolated FcR was examined. 
Materials  and Methods 
Cell Culture.  The J774 macrophage cell line, P388 lymphoma, PU 5.1 null cell line, and the 
WEHI 231 B cell line were maintained as described previously (9). The $49.1 T cell line, P815 
mastocytoma, and RAW 309 Cr. 1 macrophage cell line (all obtained from the Cell Distribution 
Center,  Salk  Institute,  La Jolla,  Calif.)  were  grown  in  a-modified  Eagle's  medium  (KC 
Biological,  Inc., Lenexa, Kans.) supplemented with 5% or 10% fetal bovine serum (FBS; heat 
inactivated at 56°C for 30 min; Flow Laboratories, Inc., Rockville, Md.); 100 U/ml penicillin, 
and  100 #g/ml streptomycin. Peritoneal  macrophages were obtained by lavage from CD2F1 
mice (Flow Laboratories, Inc.) 4 d after intraperitoneal injection of 1 ml thioglycolate broth, as 
described (19). 
35  35  Macrophages were labeled with ~ S]methionine, [  S]cysteine (>650 Ci/mmol, Amersham 
Corp., Arlington Heights,  Ill.),  or [ H]leucine  (50 Ci/mmol, New England  Nuclear, Boston, 
Mass.)  by overnight incubation in methionine-, cysteine-, or leucine-free medium, respectively. 
Radioactive amino acids were added at 50-100/~Ci/60-m  m dish. 
Monoclonal Antibodies.  Monoclonal  anti-dinitrophenyl  (DNP)  IgG1- and  IgG2b-secreting 
hybridomas DHK 109.3 and DHK 10.12 were obtained through the generosity of Dr. Norman 
Klinman  (Scripps Clinic and Research Foundation, La Jolla, Calif.).  Ascites  fluid from these 
tumors was prepared by injection of 5 ×  106 cells into CAF1 mice (The Jackson Laboratory, 
Bar Harbor, Maine)  1 wk after intraperitoneal injection of 0.5 ml of pristane (Aldrich Chemical 
Co.,  Inc.,  Milwaukee,  Wis.).  The  antibodies  were  purified  by affinity  chromatography on 
Sepharose 4B coupled with DNP12 bovine serum albumin (BSA; crystallized one-time; Sigma 
Chemical  Co.,  St.  Louis,  Mo.)  essentially  as  described  previously  (7). The anti-DNP  IgG3 
antibody 8-11-A was kindly given  to us  by Dr. Julian  Fleischman  and  Dr.  Mitchell  Scott 
(Washington  University School of Medicine,  St.  Louis, Mo.).  Monoclonal IgG1 and  IgG2b 
anti-sheep  (E)  antibodies  SP/3 and  SP/2 were from Accurate Chemical  & Scientific Corp., 
Hicksville, N. Y. The monoclonal anti-E IgG2a, UN-2, was obtained through the generosity of 
Dr. Betty Diamond (Albert Einstein College of Medicine, Bronx, N. Y.). 
The monoclonal rat anti-mouse FcR antibody 2.4G2 was prepared and purified as described 
previously (9). 
Radiolabeling of Cell Surfaces.  Plasma membrane proteins were radioiodinated using a slight 
modification of the lactoperoxidase-glucose oxidase method of Hubbard and Cohn (20)  and 
Mellman et al.  (21). Terminal galactose residues of cell surface glycoproteins were labeled by 
NaB[ H4]. In some experiments, cells  galactose oxidase oxidation followed by reduction with  3 
were preincubated with neuraminidase (22). Reagents were obtained as follows: lactoperoxidase 
(purified  grade)  and  neuraminidase  (B  grade)  from Calbiochem-Behring Corp.,  American 
Hoechst  Corp.,  San  Diego,  Calif.;  carrier-free  Na[a25I] and  NaB[aH4]  (10  Ci/mmol)  from 
Amersham Corp.; galactose oxidase and glucose oxidase (type V) from Sigma Chemical Co. 
Iodination of Proteins.  Proteins (--<50  pg) were iodinated in a vol of 0.1 ml of 0.1 M  NaPi (pH 
7) that contained 0.9/zg chloramine T and 0.5 mCi carrier-free Na[X25I] (23). After incubation 
at 4 ° for 30 rain,  10/xl  1 M  KI was added and the entire reaction mixture was passed over a 
0.3-ml column of Dowex 1 × 8 CI- (Dow Chemical Co., Midland, Mich) (in phosphate-buffered 
saline [PBS] with or without 1 mg/ml BSA) to remove free iodide. FcR was iodinated similarly 
except  that,  because the FoR was bound by the resin,  free iodide was removed by dialysis 
against PBS that contained a small quantity of Dowex 1 X 8 CI-. Adsorption of the iodinated 
FcR to glass or plastic was minimized by using tubes precoated with 2% FBS and then rinsed 
thoroughly with water. 
Immune Precipitation.  Labeled cells (0.5 ×  107-3.0 ×  107) were solubilized in lysis buffer (PBS 1050  PURIFICATION OF MOUSE  Fc RECEPTOR 
that contained 0.5% Nonidet P-40 [NP40; Bethesda Research Labs., Bethesda, Md.], 0.2 U/ml 
aprotinin, and 1 mM phenyimethyisulfonyl fluoride [PMSF; Sigma Chemical Co.]) and nuclei 
and debris were removed by centrifugation (45,000 g,  15 min at 4°C).  1 #g of 2.4G2 Fab was 
added to 0.2 ml of clarified supernate (prepared from 0.5 ×  107-1 X  107 cells) and incubated 
for 1 h on ice. Antibody-antigen complexes were recovered using 50 #i of a 50% suspension of 
affinity-purified F(ab')~ fragments of rabbit anti-rat IgG (N. L. Cappel Laboratories, Cochran- 
ville, Pa.)  coupled to cyanogen bromide (CNBr)-activated Sepharose 4B  (21).  Comparable 
results were obtained by adding 50 #1 of a 50% suspension of 2.4G2 Fab-Sepharose 4B directly 
to the cell lysate. In either case, the immunoadsorbent was incubated at 4°C with constant 
agitation for  1 h, collected by centrifugation, washed twice in buffer that  contained 0.6 M 
NaCI; 0.0125  M  KPO4, pH  7.4;  and 0.02%  NaN3  (HSA buffer), twice at room temperature 
with a mixed detergent solution (24)  (0.05% NP40; 0.1% sodium dodecyl sulfate [SDS]; 0.3 M 
NaCI; and 10 mM Tris-HC1, pH 8.6), and once again with HSA buffer. The antigen was then 
eluted in 40 #1 of electrophoresis sample buffer (2% SDS; 12% sucrose; 0.01% bromphenol blue; 
50 mM dithiothreitol; and 50 mM Na2COs buffer, pH 8.6)  by boiling for 2 min. 
Polyac~ylamide Gel  Electrophoresis (PAGE).  SDS-PAGE  was  performed  according  to  the 
method of Neville et al. (25) using 1-mm-thick slab gels with a 4-1 I% polyacrylamide gradient 
in the running gel. For samples that contained SH or SSs, gels were processed for fluorography 
as described (26) and exposed at -70°C on prefogged Kodak RP X-Omat film. 125I-containing 
lanes were dried and exposed on Kodak RP X-Omat or Du Pont Cornex film using image- 
intensification screens (Lightning Plus; E. I. Du Pont de Nemours & Co., Inc., Wilmington, 
Dei.). 
Two-dimensional PAGE was performed using a modification (27) of the original procedure 
described by O'Farrell (28).  To look for proteins with basic isoelectric points, some gels were 
run under nonequilibrium conditions (27). The pH gradient in equilibrium focusing gels was 
determined by elution of ampholytes from individual gel slices in water. Gels were dried and 
exposed as described above. 
Assay.for Solubiliaed FoR.  The concentration of FcR in solution was estimated by the ability 
of the solubilized antigen to bind ~25I-2.4G2 Fab. Small aliquots (----.20  #1) of the sample to be 
tested were  added at  various dilutions to a  1.5-ml  Eppendorf microfuge tube  (Brinkmann 
Instruments, Inc., Westbury, N. Y.)  that contained lysis buffer (50 #1) and 0.05 #g t~sI-2.4G2 
Fab  (~1.5  X  105 cpm). After 15  rain on  ice, the reaction mixture was applied to a  0.25-ml 
column ofconcanavalin A (Con A) (Sigma Chemical Co.) coupled to CNBr-activated Sepharose 
4B (29). The column was then washed four times with l-ml aliquots of PBS at room temperature 
to remove unbound radioactivity,  and then eluted twice with l-ml portions of 1% SDS. Because 
the  FcR  is a  glycoprotein, FcR-12sI-2.4G2  Fab complexes that  formed  were  bound  by  the 
column, whereas free t25I-2.4G2 Fab (which lacks carbohydrate) was eluted by the PBS washes. 
x25I was determined using a Packard Auto-Gamma Scintillation Spectrometer (Packard Instru- 
ment  Co.,  Inc.,  Downers  Grove,  Ill.).  In  each  experiment,  background  radioactivity was 
determined by including duplicate tubes to which FcR-containing samples had not been added, 
or that contained FcR that had been preincubated with a large excess of unlabeled Fab. Both 
methods yielded equivalent background binding. The assay reached a plateau when 20-25% of 
the input  I-2.4G2 Fab was bound; previous results demonstrated that  50-60% of the ~2sI- 
2.4G2  Fab  could  be  adsorbed  specifically by  J774  cells  (9).  Thus  it  is  possible  that  a 
subpopulation of FcR was not  detected by this assay. Supporting this, the amount  of FcR 
measured in lysates was approximately one-third of that detected on an equal number of cells 
by binding of a2~I-2.4G2 Fab. One unit  of FcR was defined as the amount  of antigen  that 
bound  1 #g of 2.4G2 Fab. 
Purification ofMacrophage FcR.  The antigen recognized by 2.4G2 IgG was purified from J774 
cells grown either in suspension culture or as subcutaneous tumors in syngeneic CD~F~ mice 
(Flow Laboratories, Inc.). Cell pellets and tumors were stored for up to 3 mo at -70°C before 
use. Lysates were prepared by homogenizing pellets or tumors in cold lysis buffer with a Potter- 
Elvehjem homogenizer. The homogenates were clarified by centrifugation, first at  1,600 g  (5 
min at 4°C) to remove nuclei, and then at 40,000 g (30 rain at 4°(]). The final supernate was 
removed carefully to minimize contamination by floating lipids. The Az~o  of the lysates ranged 
from  30  to 65/ml, and up to 35  ml of iysate was employed in any individual isolation. To IRA  S.  MELLMAN AND JAY  C.  UNKELESS  1051 
facilitate calculation of recoveries,  a trace amount of [35S]methionine-labeled  J774 lysate (>4 
×  107 cpm from -107 cells) was added at the homogenization step. 
Lysates were then batch-adsorbed with 2.4G2 Fab coupled to CNBr-activated Sepharose 4B 
for 1 h at 4°C with continuous agitation. Sufficient resin was added (equivalent to ~0.2 mg 
2.4G2 Fab/ml of lysate)  to remove >90% of the antigen from solution, measured as described 
above. The immunoadsorbent was washed with the same sequence of buffers as was used for 
the  immunoprecipitations. To elute the  antigen from  the resin, a  high-pH elution scheme 
similar to that used by McMaster and Williams (30) was employed. The immunoadsorbent 
was packed into a small column, equilibrated with 0.5% deoxycholate in 0.1 M Tris-HCl at pH 
7.9,  and  the  antigen eluted with  successive  column volumes of PBS  that  contained 0.5% 
deoxycholate and 0.1 M triethylamine, pH 11.5. The eluates were immediately neutralized by 
collection into tubes containing 1  M  Tris-HCI, pH  7.4  (20% of the column volume). The 
recoveries using this method were higher than those obtained by elution with 3 M ammonium 
thiocyanate, 8  M  urea,  1 M  propionic acid, or 0.5  M  acetic acid.  [35S]methionine-labeled 
proteins and antigenic content were determined in individual fractions. Peak tubes were pooled 
and dialyzed overnight against two 500-vol of PBS that contained 0.02% NaN8 and stored at 
4°C, or against one 250-vol of 0.1  M  (NH4)2COa and lyophilized. Antigenic activity was not 
destroyed  as  a  consequence of these  procedures.  Protein was  determined according to  the 
method of Lowry et al. (31) or by using a Coomassie blue binding assay (32). 
Preparation of Membranes  from J774 Cells.  J774 cells (5 ×  l0  s) were homogenized in 15 ml of 
cold 25 mM Hepes, pH 7.6 (which contained 0.2 U/ml aprotinin and 1 mM PMSF), with a 
Potter-Elvehjem homogenizer. The homogenate was centrifuged at 100,000 g (1 h at 4°C). The 
pellet was resuspended by brief sonication in the same Hepes buffer that  contained 5 mM 
MgCI2 and treated with deoxyribonuclease I (50 #g/ml; Worthington Biochemical Company, 
Freehold,  N.  J.)  for  30  min  on  ice.  Membranes  were  then  washed  by  three  successive 
centrifugations after resuspension in homogenization buffer. 
tzSI-FcR Binding to Protein-coated  Particles.  Superfine Sephadex G-25 (10-40 #m diameter) was 
activated using CNBr at  a  ratio of 200  mg CNBr:g wet  weight  of Sephadex  as  described 
previously (7). Activated beads were incubated with proteins (5 mg/ml DNPa2BSA or 5 mg/ml 
BSA per g Sephadex; 1 mg/ml LPC-1 or 1 mg/ml 2.4G2 Fab per g Sephadex) overnight with 
agitation at 4°C in PBS that contained 50  mM NaHCO3,  pH 8.7.  The amount of LPC-1, 
rabbit anti-DNP IgG, and 2.4G2 Fab bound (determined by radioactivity bound from a trace 
amount of lZSI-protein added  in the initial incubation) was 300/~g,  270 ~g, and  120 /xg/g 
Sephadex, respectively. DNPlzBSA-Sephadex beads were coated with anti-DNP IgG or F(ab')2 
fragment by incubation at room temperature for 15 min with frequent agitation. Essentially all 
the IgG or F(ab')2 fragment added bound to DNPlzBSA Sephadex, up to a concentration of 
200 #g protein/ml packed Sephadex. On the other hand, BSA-Sephadex beads bound <0.2% 
of the input ~zSI-packed rabbit anti-DNP IgG. 
All binding studies of x2SI-FcR were  performed  in  PBS  that  contained  1-2%  FBS.  The 
addition of FBS did  not  affect  the specific  binding, but  had  a  marked  effect  on  lowering 
nonspecific binding to the Eppendorf centrifuge tubes. BSA was not an effective substitute for 
FBS. 125I-FcR  was added to 5-10 #1 of coated Sephadex beads in a total vol of 50 pl, incubated 
at room temperature for 15-30 min, and the Sephadex was then rinsed with three 1-ml washes 
of PBS that contained 1% FBS. Bound radioactivity was assayed in a Packard gamma counter. 
....  125T  Similar procedures were followed  for binding of  I-FcR to IgG-coated erythrocytes. 
To test the binding  of 125I-FcR as a function of pH, DNPI2BSA Sephadex beads coated with 
rabbit anti-DNP IgG or its F(ab')2 fragment were equilibrated in buffer (50 mM acetate; 50 
mM phosphate; 50 mM borate) that contained 1% FBS adjusted to desired pH values with 
NaOH. The binding assay contained 30 ~1 of buffer, 5 #1 of xzsI-FcR diluted 1:10 in 0.15  M 
NaC1 (2.5 ×  10  -3 U, 1 ×  104 cpm), and 10 #1 of coated Sephadex beads. After incubation, tubes 
were rinsed twice with 1-ml portions of the same pH buffer used in the incubation, and assayed 
for bound radioactivity. To test for renaturation, FcR adjusted to pH 4 in the above buffer and 
kept at room temperature for 30 min was then neutralized with 1 M Tris base before assay as 
usual. The ~25I-FcR-binding activity was unaffected by digestion with 80 pg/ml phospholipase 
C  (from Bacillus cereus; grade II; C. F. Boehringer and Sons, Mannheim, Federal Republic of 
Germany) for 30 min at 37 ° in PBS that contained 1.5 mM CaC12 and 10 mM MgC12). 1052  PURIFICATION  OF  MOUSE  Fc  RECEPTOR 
Binding of I~I-Proteins to Intact Cells.  Binding of a25I-proteins to cells was  performed as 
described  previously  (6-9).  Cells  (2  ×  105-4 x  105) plated  in  16-ram wells  (Costar,  Data 
Packaging, Cambridge, Mass.) were incubated with 0.3 ml of x~I-protein in PBS that contained 
1 mg/ml BSA for 1 h at 4°C. The radioactive mixture was then rapidly aspirated and the trays 
were dipped into two successive beakers filled with 2 liters of cold PBS. Excess fluid was again 
aspirated, and the wells swabbed with Q-tips  (Cbesebrough-Ponds,  Inc., Greenwich,  Conn.) 
which were then assayed for radioactivity. Nonspecific (nonsaturable)  binding was assessed by 
binding of t2nI-protein of low specific activity. All determinations were performed in triplicate 
and experimental values did not differ by >10%. 
The dissociation of bound x~I-2.4G2 Fab from J774 cells was measured in the presence of 25 
#g  of unlabeled  2.4G2  Fab.  Pseudo-first-order  association  constants  were determined  for 
concentrations of t~I-Fab from 2 ×  10  -8 to 8 ×  10  -s M. These constants were plotted against 
concentration to obtain the rate of association. 
Results 
Antigen on Murine Cells and Cell Lines Recognized by 2.4G2 IgG.  Because FcR have 
been described on a variety of lymphoid cell lines and cell types, it was of interest to 
compare the antigens recognized by the monoclonal anti-mouse FcR antibody 2.4G2 
on representative FoR-bearing cells.  Two immune precipitation systems were used 
with equivalent results. Labeled cell lysates were incubated either with 2.4(32 Fab (or 
IgG)  coupled to Sepharose 4B or with  free 2.4(32, after which,  immune complexes 
were isolated using Sepharose 4B coupled with rabbit anti-rat IgG F(ab')2 fragments 
(21). 
As  shown  in  Fig.  1,  the  iodinated  antigens  isolated  from  different  cell  types 
displayed  significant  heterogeneity  in  Mr  after  SDS-PAGE,  ranging  from  70,000 
(WEHI  231  B  cell line)  to 47,000  (thioglycollate-elicited mouse peritoneal  macro- 
phages). The antigen isolated from the J774 macrophage cell line had two components, 
a major band centered at 60,000 Mr and a minor band at ~47,000 Mr. No other low 
molecular weight  components were consistently observed.  Electrophoretic patterns 
were similar  when  SDS-PAGE  was  carried  out  under  reducing and  nonreducing 
conditions, indicating the absence of extensive interchain disulfide linkages. 
The breadth of the radioactive bands in Fig.  1 is also noteworthy, with a spread of 
up to  10,000 Mr.  This observation suggested  that  the antigen  recognized by 2.4G2 
Fab was glycosylated. To test this hypothesis, immune precipitation was performed 
using  NP40  lysates  of J774  cells  previously  labeled  by  NaB[all]4  reduction  after 
galactose oxidase treatment,  a  procedure that  results  in  the  tritiation  of terminal 
galactose  residues  (22).  As  shown  in  Fig.  2,  radiolabeled  antigen  was  detected, 
indicating the presence of carbohydrate. More radioactivity was incorporated when 
the cells were treated with neuraminidase before galactose oxidase, suggesting that 
sialic acid was  also present.  The antigen could also  be labeled  metabolically with 
[aSS]methionine (Fig. 2), [aSS]cysteine,  and [3H]leucine (data not shown). 
Trypsin treatment of J774 cells  (1  mg/ml of trypsin for 30 min at  37 °)  did not 
reduce the binding of 1~I-2.4G2 (data not shown) but resulted in a slight shift of FcR 
to lower Mr. In immune precipitates from lysates of  cells iodinated after trypsinization, 
the lower Mr species of the two J774 bands appeared to be more prominent (Fig. 2). 
Assay for Soluble FcR.  Before attempting to isolate the FcR in larger amounts, we 
developed a quantitative assay for the antigen in solution to enable us to monitor the 
purification. The assay was based on the ability of Con A-Sepharose to retain ~25I- 
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Fla.  1.  Antigens recognized  by 2.4G2 on different FcR-bearing cell types.  Cells  were iodinated 
using laetoperoxidase-glucose  oxidase and then lysed  in NP40.  Immune precipitations were per- 
formed as detailed in Materials and Methods. No radioactive bands were detected when 2.4G2 was 
omitted. From left to right the cell types shown are: J774 (macrophage), P388  (null lymphocyte), 
PU 5.1  (null  lymphocyte), thioglycollate-elicited macrophage (TEM), P815  (mastocytoma), RAW 
309 Cr.1  (RAW 309) (macrophage),  $49.1 (T lymphocyte), and WEHI 231  (B lymphocyte).  No 
antigen was detected in iodinated NP40 lysates of the FcR-negative derivative ofJ774, MNNG 6.31 
05). 
hydrate).  Aliquots of the  samples  to  be  tested  were  incubated  with  lZSI-2.4G2  Fab 
until equilibrium  was reached  (15 rain  at 0 °) and  then passed  over small columns of 
Con A-Sepharose. The radioactivity specifically retained  by these columns was linear Fie.  2.  Characterization of the antigen recognized by 2.4G2 Fab on J774 macrophages. Lanes . 
4:  immune precipitation  from J774  cells.  Lanes  1 and  4, J774  cells labeled by  lactoperoxidase- 
glucose oxidase catalyzed iodination; lane 2, cells labeled by galactose oxidase followed by reduction 
with NaB[aH4];  lane 3, cells labeled by overnight incubation in [anS]methionine-containing medium. 
The cells in lane 4 were treated with  1 mg/ml of trypsin (15 rain at 37°C) before iodination. Lane 
5, antigen isolated from J774  tumors and stained with Coomassie brilliant blue.  Lane 6, antigen 
isolated from J774 tumors, iodinated in vitro with chloramine T. 
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FIG. 3.  Con A-Sepharose assay for solubilized FcR. J774 cells (8.7 x  107) were vortexed in 1 ml of 
lysis buffer. After centrifugation  to remove nuclei and debris, ~28 mg of protein remained in the 
supernate. Aliquots of lysate were added to 50-#1 portions of lysis buffer, mixed with ~2nI-2.4G2  Fab 
(50 ng;  1.1  X  106 cpm/#g), and processed as described. The number of FcR sites assayed in this 
experiment was 1.9 X 105 sites/cell, somewhat lower than the saturation binding of ~25I-2.4G2 Fab 
to the intact cells, which was 6 X  105 sites/cell  (9). Background binding was not subtracted.  (C)) 
Binding after 10 p.l ofJ774 lysate was preincubated with 10 #g of 2.4432 Fab. 
TABLE  I 
Purification of FoR from J774 Tumors by Affinity Chromatography with 2. 4G2 Fab-Sepharose 
Protein*  [~S]Methionine  FcRdd  Specific 
activity 
mg  cpm  U  U/mg protein 
NP40 homogenate§  1337.7  3.36 X 10  7  139  0.1 
Column eluate  0.149  1.38 X 104  79  530.2 
(Recovery)  (0.011%)  (0.041%)  (57%) 
§ The initial homogenate was centrifuged  (1,600 g for 5 min) to remove nuclei and debris; the resulting 
supernate  was designated  NP40  homogenate.  The protein and  [~S]methionine  values of the  initial 
homogenate were approximately twofold greater. 
* Protein was determined using the Coomassie blue binding assay (32). 
:l: Determined as described in Materials and Methods.  1 U is ~ 1 #g FcR. 
with respect to the amount of protein added (Fig. 3);  1 U  of FcR was defined as that 
amount of antigen capable of binding 1 #g of 2.4G2 Fab. 
Purification  and Biochemical  Characterization  of the FoR.  The procedure developed for 
the large scale purification of the FcR was  fundamentally the same as the immune 
precipitation  protocol  described  above.  NP40  lysates  (which  contained  1-2  g  cell 
protein) were prepared from subcutaneous J774 tumors. After batch-adsorption with 
2.4G2 Fab-Sepharose, the resin was washed extensively, and bound antigen was then 
eluted with 0.1  M  triethylamine (pH  11.5)  in 0.5% deoxycholate (30)  (Materials and 
Methods). 
A  typical purification, in which a  lysate of [~S]methionine-labeled J774  cells was 
added to the tumor lysate to facilitate calculation of yields, is shown in Table I. The 
overall recovery of FcR in different experiments varied from  40-80%,  with  specific 
activities of the isolated material >5,000-fold greater than the initial lysate, cleared of 
nuclei.  This  purification  factor is consistent  with  the  theoretical yield, because the 
percentage abundance of a  50,000-dahon  protein (present at 500,000  molecules/cell 
[9]) should be ~0.01%, given 300 pg protein/J774 cell. 1056  PURIFICATION OF  MOUSE  Fc  RECEPTOR 
Sufficient  antigen  was  isolated  to  be  visualized  by Coomassie  blue  staining  after 
SDS-PAGE.  As shown  in  Fig.  2,  the  electrophoretic  profile of the  purified  material 
was essentially  identical  to that  obtained  after immune  precipitation  from lysates of 
iodinated  or metabolically labeled J774  cells  (Figs.  1 and  2). No significant  contami- 
nation  by unrelated  polypeptides  was observed.  The three  low Mr bands  visible just 
behind  the  electrophoretic  front  probably  represent  2.4G2  light-chain  and  heavy- 
chain  fragments  dissociated  from  the  CNBr-activated  Sepharose  by  nucleophilic 
displacement  during the high-pH elution step. 
To facilitate study of the small  amount  of purified  antigen,  protein  stripped  from 
the affinity column  was iodinated  using chloramine  T  after dialysis against  PBS.  As 
shown  in  Fig.  2,  the electrophoretic  profile of the  isolated  material  iodinated  in this 
way  was  the  same  as  that  detected  by  Coomassie  blue  staining  or  by  immune 
precipitation  from  lactoperoxidase-iodinated  or  [~S]methionine-labeled  cells.  The 
~2SI-labeled  protein  was  further  characterized  by two-dimensional  PAGE,  in  which 
the  isoelectric-focusing  dimension  was  performed  under  nonequilibrium  conditions 
(27)  to retain  proteins  with  basic  isoelectric  points on  the gel.  As shown  in  Fig.  4A, 
there are again clearly two components  of the J774  FcR,  and  a  series of components 
of low Mr, which probably are contaminating 2.4G2 light- and heavy-chain fragments. 
Digestion of the 12SI-FcR preparation with neuraminidase  (Fig. 4 B) resulted  in a  shift 
of the 47,000 and 60,000 Mr components to more basic positions relative to the low Mr 
peptides, which  strengthens  the conclusion  that  the FcR contains  sialie acid. 
To  estimate  the  Mr  of  the  isolated  FcR  in  aqueous  solution,  a  sample  of  the 
iodinated  material  was  first  subjected  to gel  filtration  on  a  column  of Sephadex  G- 
Fie.  4.  Analysis of the isolated 2.4G2 antigen by two-dimensional PAGE. 2.4G2 antigen, purified 
from J774 tumors and iodinated in solution using chloramine T, was analyzed by two-dimensional 
electrophoresis (26) and visualized by radioautography.  Isoelectric focusing (horizontal dimension) 
was performed under nonequilibrium conditions (27) to retain species with alkaline isoelectric points 
on the gel. (A) Iodinated material without further treatment.  (B) Material digested with neuramin- 
idase (50 U/ml at 37°C for 30 min). Note that neuraminidase  treatment shifts the position of the 
major radioactive bands  (toward the alkaline side of the gel) relative to a series of minor punctate 
spots of lower M,. These low Mr spots probably represent contaminating  2.4G2 light- and heavy- 
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FIG. 5.  Chromatography of purified I~I-FcR on Sephadex G-150. Labeled FcR (5.9 ×  10  7 cpm; 
1 U) was applied to a 1.4- X 75-cm  column of fine Sephadex G-150 and eluted with 0.5 M NaCI-50 
mM NaPO4 buffer at a flow rate of 3 ml/h. To minimize adsorption of labeled material, fractions 
were collected in glass tubes previously coated with  1% FBS and rinsed exhaustively with water. 
The recovery of radioactivity applied to the column was 60%. Of the initial lmI-FcR,  35% bound to 
rabbit anti-DNP IgG-coated DNPl2BSA-Sephadex G-25 beads; control DNP12BSA beads bound 
0.7% of the input. Specific binding  of iodinated proteins to IgG-coated beads was found only in the 
void-volume  peak. IgG-coated beads bound 54% of the input radioactivity, the F(ab')2 control was 
0.3%, and the uncoated DNPj2BSA Sephadex bound 1.3% of the input. 
150.  Approximately 50% of the radioactivity eluting from the column was found in 
the void volume peak (Fig. 5), suggesting the presence of large aggregates. SDS-PAGE 
of column fractions confirmed that the protein previously identified as the FcR from 
surface  iodinated cells was  found only in  the  void  volume.  2 The  size  of the  FcR 
aggregates  was  then  assessed  by  velocity sedimentation analysis in  5-20%  sucrose 
gradients. The iodinated material exhibited a  broad peak at  ~15S, extending well 
past  the IgM marker (Fig. 6).  In addition, a  variable amount of radioactivity (10- 
30%)  sedimented to the 60% sucrose cushion. Thus, in aqueous solution, the isolated 
antigen formed high-order aggregates of at least  10-20 subunits. 
Activity  of the  Isolated  FcR.  Circumstantial evidence based  on  the  restriction of 
binding of 2.4132  IgG to FcR-bearing cells, and the subsequent inhibition of rosette 
formation  by  EIgG  on  cells  preincubated with  2.4G2  IgG,  suggested  the  antigen 
z In the experiment shown, nonspecific  adsorption to the tubes was avoided by precoating with serum, 
which resulted in a slight contamination with serum albumin (see Fig. 5, lane B). This iodinated band was 
not observed in other experiments in which serum coating of the tubes was omitted. 1058  PURIFICATION  OF  MOUSE  Fc  RECEPTOR 
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FIc.  6.  Sucrose density velocity sedimentation of 125I-FcR. Labeled FcR (4.7 X  104 cpm, ~0.01 U) 
was  layered over a  5-20% sucrose gradient  buffered with  50  mM Tris-HCl,  pH 8,  with a  l-ml 
cushion of 60% sucrose, and centrifuged in a  Beckman SW-40 rotor (Beckman Instruments, Inc., 
Spinco Div., Palo Alto, Calif.)  for 8  h  at  4°C.  Fractions (0.5  ml)  were collected and assayed for 
radioactivity. Companion gradients contained marker proteins LPC-1  (IgG)  and a  human  IgM 
myeloma protein (courtesy of Dr. Shu Man Fu, The Rockefeller University, New York). 
recognized by  2.4G2  IgG  was  an  FcR.  Using  two  different  approaches,  we  then 
determined directly whether the isolated antigen exhibited FcR activity in vitro. 
(a)  Hemagglutination Enhancement by FcR.  Because the isolated FcR  formed large, 
presumably muhivalent aggregates in solution, we reasoned that  if it retained FcR 
activity, it should potentiate the agglutination  of EIgG.  E  were derivatized with  a 
trinitrophenyl  (TNP)  moiety  (ETNp) (33)  and  then  coated with  serial  dilutions  of 
affinity-purified  rabbit  anti-DNP  IgG  (ET~pIgG)  or  its  F(ab')2  fragment.  In  the 
presence of as little as 0.1  U/ml FcR, the ETNpIgG formed large aggregates (within 
15-30 min at room temperature) that could not be dispersed by vigorous vortexing. 
In  contrast,  Ewr~e hemagglutinated  only by  the  addition  of rabbit  anti-DNP  IgG 
could be readily dispersed by such treatment (Fig. 7). This effect was specific for the 
Fc domain of the  rabbit  IgG;  no enhancement of hemagglutination  was  observed 
when FcR was added to either ETNP or ET~p coated with an equivalent hemaggluti- 
nating titer of anti-DNP  F(ab')2.  Even more-striking results were obtained with  E 
coated with  the IgG2b anti-E monoclonal SP/2  and the IgG2a anti-E monoclonal 
U88.  These monoclonal antibodies  did  not  by themselves cause  hemagglutination 
and, thus, hemagglutination of E coated with SP/2 or U88 was observed only when 
FcR was added. 
(b)  Binding of IeSI-FcR to Immobilized lgG.  To verify that  the isolated antigen was 
binding to IgG, we assessed the interaction between the purified FcR and IgG immune 
complexes. For this purpose, IgG was immobilized on several different particles. First, 
we determined the extent to which  a2SI-FcR bound to erythrocytes opsonized with 
mouse monoclonal  IgG1,  IgG2a,  and  IgG2b  anti-E  antibodies.  As  summarized  in 
Table II, the iodinated material bound most effectively to IgG2b and IgG2a-coated 
E. Significant, but somewhat  lower, amounts of 125I-FcR bound to IgGl-coated E. 
The  maximum  binding  observed  was  ~50%  of the  added  radioactivity,  whereas 
<0.5% of the radioactivity bound to uncoated E. 
A  second set  of binding  studies  was  performed using CNBr-activated  Sephadex 
beads  (7)  to which either IgG2a (the mouse myeloma protein LPC-1), rabbit  anti- 
DNP IgG, or DNP12BSA was coupled. The DNP-BSA-Sephadex beads were in turn 
coated with antibody by incubation with rabbit anti-DNP IgG [or F(ab')2] or any of IRA S.  MELLMAN AND JAY C.  UNKELESS  1059 
Fro.  7.  Enhancement of hemagglutination by purified FcR. Erythrocytes  (50 #1; 0.25% vol:vol  in 
PBS that contained 2% FBS) derivatized with TNP groups as described by Rittenberg and Pratt 
(33) were incubated with anti-DNP IgG or F(ab')2 fragment (50 ffl) and allowed to stand for 2 h. 
The last hemagglutinating well contained  1 #g/mi of IgG or F(ab')z fragment. The cells were 
washed twice by centrifugation with 50 #1 portions of PBS. Then, 10/xl of FcR (5 U/ml) in PBS or 
10 pl were added, mixed by vortex, and allowed to stand at room temperature for 30 min with 
intermittent mixing. Finally, the trays were vortexed vigorously  and photographed 10 min later. 
a  series of monoclonal  anti-DNP  antibodies  of different  subclasses.  Data  obtained 
using  these  particles  were  substantially  in  agreement  with  the  results  of the  IgG- 
coated  E  experiments:  IgG1,  IgG2a,  and  IgG2b  subclasses  all  bound  significant 
amounts of I~I-FcR, whereas only negligible binding was observed to either DNP- 
BSA beads or rabbit anti-DNP F(ab')2 beads  (Table II). In addition,  no significant 
binding was observed to beads coated with an anti-DNP IgG3 monoclonal antibody. 
The binding of the 125I-FcR to IgG2a- and IgG2b-coated beads was totally inhibited 
by both 2.4G2 IgG and Fab. This suggests that IgG2a and IgG2b may interact with 
the same or sterically adjacent sites on the purified receptor. 
Although measurable binding was seen at extreme dilutions of 12SI-FcR (<1 ×  10  -s 
U/ml), no meaningful association constant could be measured because the receptor 
was found to exist in large, presumably multivalent aggregates in PBS (Fig. 6). NP40 
(0.5%)  inhibited  binding  80%  relative  to  control,  and  0.5%  deoxycholate  totally 
abolished activity (Table I!). 
(c) Acid Lability ofFeR Activity.  We examined the pH dependence of the binding 
reaction.  Interestingly,  mI-FcR binding  fell off quite  rapidly between  pH 4  and  5 
(Fig.  8),  an  acidity  that  approximates  the  intralysosomal  environment  (34).  This 
inactivation of I~I.FcR activity was reversible:  upon  neutralization  of the reaction 
mixture,  >80%  of the  initial  binding  activity was  recovered after a  brief (30  min) 
exposure to pH 4 buffer at room temperature. 1060  PURIFICATION  OF  MOUSE  Fc  RECEPTOR 
TABLE  II 
Binding of t~I-FcR to IgG-coated Particles 
Binding (per- 
Experimental particle  Preincubation with  cent of input 
12~I-FcR) 
I.  E  0.43 
E IgGl  18 
E IgG2a  28 
E IgG2b  49 
II.  DNP-Sephadex 
DNP-Sephadex-rabbit anti-DNP (ab')~ 
DNP-Sephadex-rabbit anti-DNP IgG 
Rabbit IgG-Sephadex* 
DNP-Sephadex-anti DNP IgGt 
DNP-Sephadex-anti DNP IgG2b 
DNP-Sephadex-anti DNP IgG2b 
DNP-Sephadex-anti DNP IgG2b 
IgG2a-Sephadex* 
IgG2a-Sephadex* 
IgG2a-Sephadex* 
DNP-Sephadex-anti-DNP IgG3 
2.4G2 IgG 
2.4G2 Fab 
2.4G2 IgG 
2.4(32 Fab 
0.66 
0.21 
29 
29 
7.6 
28 
0.51 
0,18 
25 
0.58 
0.62 
0.41 
III. DNP-Sephadex-rabbit anti-DNP IgG 
DNP-Sephadex-rabbit anti-DNP IgG 
DNP-Sephadex-rabbit anti-DNP [gG 
DNP-Sephadex-rabbit anti-DNP F(ab')2 
DNP-Sephadex-rabbit anti-DNP F(ab')u 
DNP-Sephadex-rabbit anti-DNP F(ab')u 
--  35 
0.5% NP40  8.0 
0.5% deoxycholate  0.38 
--  0.21 
0.5% NP40  1.0 
0.5% deoxycholate  0.38 
Erythrocytes (0.5 ml; 5% vol:vol) were incubated with U88 (IgG2a), SP/2 (lgG2b),  or SP/3 (IgGl) ascites 
fluid  (20 #1)  at 4°C for  1 h, washed twice by centrifugation, and resuspended at 5% col:col in PBS that 
contained 2% FBS. I~I-FcR from the Sephadex G-150 void-volume peak (20 #1; 3 ×  10  -a U; 40,000 cpm), 
adjusted with water to 0.154 M  NaCI, was added to 50 #1 of the erythrocyte suspension.  Experiments II 
and III were performed with material from a Sephadex G-150 column (50/d;  1 X  10  -a U; 3,000 cpm). 
DNP-Sephadex was coated with 200/~g rabbit IgG or F(ab')2/ml packed volume of beads or with 160 p,l 
ascites fluid/ml packed volume.  Preincubations of 125I-FcR with 2.4G2 IgG or Fab were performed at a 
final concentration of 100 #g/ml for 15 min at room temperature before the coated Sephadex beads were 
added. In experiment III, detergent was present in incubation and wash buffers. 
* Antibody coupled to CNBr-activated Sephadex (Materials and Methods). 
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FIo.  8.  Binding of l~I-FcR as a function of pH. Binding of l~I-FcR to DNPI2BSA-Sephadex  beads 
coated with rabbit anti-DNP IgG or its F(ab% fragment at different pH values was determined as 
described in Materials and Methods. The binding of I~I-FcR to F(ab%-coated beads at pH 6 was 
1.5% of the input;  maximum binding to IgG-coated beads was 40%. Data presented have been 
corrected for binding to F(ab%-coated beads incubated in parallel at each pH. IRA S.  MELLMAN AND JAY C. UNKELESS  1061 
Association of FcR with Membranes.  We were interested in defining the nature of the 
association between the antigen recognized by 2.4G2 and the plasma membrane. By 
employing the assay for soluble FoR described above, we found that the receptor was 
not released from a preparation of total J774 membranes by sonication;  1.5 M  NaCI; 
Na2CO3, pH  10.8; or 1 mM EDTA (Table III). Solubilization occurred only after the 
membranes were disrupted by nonionic detergent (0.5% NP40). Thus, the FcR can be 
defined as an integral membrane protein (35)  that presumably extends into or across 
the lipid bilayer. 
Identity of the Functionally Active FcR and 2. 4G2 Antigen.  Because the 125I-FcR bound 
with high avidity to IgG-coated Sephadex, we could compare the proteins absorbed 
to the IgG-coated beads and the proteins immunoprecipitated by 2.4G2 Fab coupled 
to CNBr-aetivated Sephadex. The results (Fig. 9) show a virtual identity between the 
l~I-protein that was immunoprecipitated by 2.4432 Fab and the l~I-protein that was 
bound by the IgG-coated Sephadex. The initial lzSI-FcR preparation contained some 
low Mr peptides (Fig. 9, left panel). Because these were absent in the re-isolated FoR 
(Fig. 9, middle and right panels) we conclude they have no relation to either antigenic 
or functional aspects of the FcR. 
Binding of l~I-proteins  to FcR of Macrophages.  To confirm previous experiments  (9) 
that demonstrated that 2.4G2 Fab distinguished between the binding sites for IgG2b 
and IgG2a in the plasma membrane, we performed a series of quantitative inhibition 
of binding  studies  using  the  macrophage cell  lines J774  and  RAW  309  Cr. 1.  The 
binding of iodinated rabbit IgG in immune complexes (which binds primarily to the 
trypsin-resistant IgG2b receptor [3, 7, 8]) and that of 12~I-LPC-1  (an IgG2a myeloma 
protein  that  binds  to a  trypsin-sensitive site  [6-8])  was determined  in  the  presence 
and  absence  of 50 #g/ml  2.4G2  Fab  (Fig.  10).  The  number  of sites  for  IgG2a at 
saturation was decreased by only 15% in the presence of 50 #g/ml of 2.4G2 Fab; the 
TABLE III 
Solubilization of the 2.4G2 Antigen  from J774 Membranes 
Treatment  Antigen solubilized 
U 
I.  0.5% NP40 
1 mM PMSF  29.15 
0.2 U/ml aprotinin 
II.  1.5 M NaCI  6.85 
IlL 0.05 M NazCOs, pH 10.8  5.70 
IV. 25 mM Hepes, pH 7.6 
1 mM PMSF 
0.2 U/ml aprotinin 
1 mM EDTA 
6.80 
Crude J774 membranes  were prepared as described in Materials and Methods. 
Equal amounts of membranes  were then resuspended in the indicated solutions 
and incubated with constant agitation for 10 rain at room temperature in a 
final vol of 0.5 ml. Samples were then centrifuged for I h at 100,000 g (4°C) 
and the resulting supernates assayed for soluble FcR (Materials  and Methods). 
0.5% NP40 was found to solubilize -60% of the detectable antigenic activity 
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Fro.  9.  Analysis of iodinated proteins that bind to 2.4G2 Fab-Sephadex and rabbit IgG-Sephadex. 
Left panel, I~I-FcR preparation analyzed by two-dimensional gel electrophoresis with the isoelectric 
focusing (horizontal direction) performed under equilibrium conditions. Center, l=6I-proteins bound 
by 2.4G2 FaD coupled to CNBr-activated Sephadex, eluted with 1% SDS, and analyzed as above. 
Right, 12hi-proteins bound by DNPIsBSA Sephadex coated with rabbit anti-DNP IgG. See Materials 
and Methods for details. 
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FIo.  10.  Binding of IgG2a and soluble rabbit immune complexes to RAW 309 Cr. 1 cells  in the 
presence and absence of 50 ~.g/ml of 2.4G2  Fab. RAW 309 Cr.1 cells  (5 X  l0  s) seeded in  16-ram 
wells were incubated at 4°C for 60 rain with a constant input of I~ZI-LPC-1 (10 ng; 6.2 ×  107 cpm/ 
#g) and unlabeled LPC-I in a final vol of 0.3 ml (A); or with 12Zl-rabbit anti-DNP IgG DNP1zBSA 
complexes  (1.48  X  104  epm//~g)  formed  at  an  antibody:antigen ratio  of 5:1  (B).  Background 
(nonsaturable) binding was assessed  with low specific  activity LPC-I  mixtures and with F(ab')2 
complexes.  (O) Binding in the absence of 2.4G2  Fab; (O) binding in the presence of 50 #g/ml of 
2.4G2  Fab. 
association constant (K~) for LPC-1 was unaffected (Table IV). In contrast, addition 
of the 2.4G2  fragment  resulted in a  dramatic  (10-fold)  inhibition  of the binding of 
rabbit IgG in immune complexes, to approximately the same number of sites (80,000) 
as IgG2a. This may be significant  because rabbit  immune complexes bind to both 
trypsin-sensitive and -resistant sites (3, 8). Thus, in agreement with previous results in 
which the binding of IgG2a-coated E  to J774 was examined,  2.4432 Fab had little 
effect on the binding of monomeric IgG2a to RAW 309 Cr. 1. Similarly, 2.4432 Fab 
had little effect on the binding of IgG2a to J774 cells (data not shown). There were 
more binding sites at saturation for rabbit IgG in immune complexes (750,000)  than 
for IgG2a (107,000) or 2.4432 Fab (350,000), which also argues that the FcR for IgG2a 
and rabbit IgG in complexes differ. 
The lack of inhibition observed by 2.4G2 Fab for IgG2a binding could be explained IRA S. MELLMAN AND JAY C.  UNKELESS 
TABLE IV 
Binding of Immunoglobulins and 2.4G2 Fab to Macrophage Cell Lines 
1063 
Cell  l~l-protein tested  Addition  K.  Sites/cell  k.n  ko. 
M-t  min-t  (M-t.min -t) 
RAW 309 Cr.I  LI~-I  (l~2a,  J¢)  --  6.0 X  107  107,000 
LPC-I  (lgG2a, i¢)  2.4G2 Fab (50 ~g/rnl)  5.4 ×  10  r  91,000 
Rabbit anti-DNP IgG  --  1.9 ×  107  750,000 
DNPI2BSA complexes* 
Rabbit anti-DNP lgG  2.4G2 Fab (50 #g/ml)  3.6 X  107  80,000 
DNPI2BSA cgmplexes* 
2.4432  Fab  --  1.7 X  IO  s  350,000 
2.4G2 Fab  --  1.3  X  IOS:~  2.3  X  10  -3  3  X  10  s 
LPC-I  (IgG'2.a,~¢)  --  1.1X  108(6)  8.3X  10-2 (6)  9×  10~ (6) 
J774 
P388DI 
All ~says were performed at 4°C e~sentially as described in Materials and Methods. Pseudo-first-order K. were determined for concentrations 
of Fab from 2 X  l0  -s M  to 8 X  10  -s M. The slope of these constants plotted against concentration  was used to determine k~ (36). 
* The rabbit IgG was labeled. Binding and saturation data are expressed with regard to IgG concentration,  not complex concentration. 
From lq,./k,,cr. 
if the Ka of IgG2a were much greater than that  of 2.4G2 Fab.  However the K~ of 
2.4132 Fab at 4°(3 was >1  ×  10  a M -1 and the ta/2 for dissociation >4 h; both of these 
values are far greater than the corresponding values determined previously for IgG2a 
binding:  ~I  X  10  a M -1 and 8 min  (6).  The inhibition studies  2.4G2 Fab on intact 
macrophages, the binding of the purified FcR to both immobilized IgG2a and IgG2b, 
and the inhibition of the purified FcR binding to IgG2a and IgG2b by 2.4G2 Fab all 
indicate that the purified FcR has a somewhat altered specificity from the molecule 
in the macrophage membrane. 
Discussion 
The use of cell  hybridization  to raise  monospecific, homogeneous antibodies  as 
pioneered  by  KShler  and  Milstein  (37)  can  greatly  facilitate  the  study  of  the 
biochemistry and  function of cell surface receptors.  Recently, we  reported  (9)  the 
isolation of a rat monoclonal hybrid, 2.4G2, that secretes an IgG directed against the 
trypsin-resistant mouse FoR, which binds aggregated IgG1 and IgG2b. In the present 
study, we have used this antibody as an affinity reagent to isolate FoR in quantities 
sufficient for biochemical analysis. The high degree of specificity and affinity of 2.4G2 
Fab for its antigen enabled the purification of the receptor to apparent homogeneity 
in one step. The mouse macrophage cell line J774 was chosen as the source of FcR 
because quantitative binding studies using a~zI-2.4G2 Fab (9) indicated that these cells 
possessed the greatest number of receptor sites/cell (>500,000) of the cell lines tested. 
Furthermore, J774 cells could be readily grown as subcutaneous tumors in syngeneic 
mice, thus providing a convenient means to prepare large amounts of tissue. 
FcR isolated from J774 cell lysates using 2.4G2 Fab-Sepharose was found to consist 
of two components with 60,000 and 47,000 Mr. That these polypeptides were glyco- 
sylated was indicated by labeling with the galactose oxidase-NaB[aH]4 procedure (22) 
and by their affinity for Con A-Sepharose. Similarly, the presence of sialic acid was 
demonstrated  by  the  shift  to  a  more  basic  isoelectric  point  after  digestion  with 
neuraminidase. However, the most significant aspect of this Work was the demonstra- 
tion that the isolated antigen exhibited FcR activity in vitro. 
Two different  methods  were  used  to  demonstrate  functional  activity.  First,  the 1064  PURIFICATION OF MOUSE Fc RECEPTOR 
purified  receptor was  found  to  dramatically  enhance  the  hemagglutination  of E 
sensitized with rabbit antibody, mouse IgG2b, or IgG2a. Rabbit IgG-coated E were 
agglutinated  in  the  presence of even small  quantities  of FcR  (0.1  U/ml),  forming 
tight,  nondispersable clumps.  The enhancement  was specific for the Fc domain  of 
IgG,  because  E,rNP coated  with  an  equivalent  hemagglutinating  concentration  of 
rabbit  anti-DNP  F(ab')2 were unaffected by even high concentrations  (5  U/ml)  of 
FcR. 
To  provide a  more  readily  quantifiable  measure  of activity,  purified  FcR  was 
iodinated  in  vitro to allow  us  to  measure  the  binding  of the  FoR  to  IgG-coated 
surfaces. These experiments demonstrated that  up to 50% of the iodinated protein 
could bind to IgG. Furthermore, this interaction, like the hemagglutination enhance- 
ment  noted  above,  was  dependent  on  the  Fc  domain,  because  the  binding  to 
nonopsonized or F(ab')2-coated beads was <1%.  Because the iodinated FeR bound 
with high avidity to IgG-coated beads, we could demonstrate directly that the antigen 
immunoprecipitated by 2.4G2 Fab and immune complexes was the same, thus proving 
that the antigen recognized by 2.4G2 is indeed an FoR. 
Interestingly, however, the  purified  FcR  did  not  exhibit  the  same  IgG subclass 
specificity in solution as in the plasma membrane of intact cells. Considerable evidence 
(2-4)  suggests  that  IgG2a  and  IgG2b  bind  to different sites  based  on  the  lack  of 
inhibition of each subclass for binding of the other. Indeed, as discussed previously, 
the 2.4G2 Fab  inhibited the binding to macrophages of IgG1  and  IgG2b, but  not 
IgG2a immune aggregates. Of the mouse IgG subclasses, the 125I-FcR failed to bind 
only to IgG3 immune aggregates. Furthermore, the binding of x25I-FcR to both IgG2a- 
and IgG2b-coated beads was totally inhibited by 2.4G2 Fab. This is quite different 
from the inhibition of IgG2a binding to intact cells, which is inhibited only 15% by 
inclusion of 1 X  10  -6 M  Fab in the incubation mixtures. It is unlikely that this lack 
of inhibition is a result greater affinity of IgG2a for the FcR than 2.4G2 Fab because 
the Ka for 2.4G2 Fab is 109 M -1,  10-fold higher than that of IgG2a. 
Any of several  factors might  account  for the  loss  of specificity observed for the 
purified FcR. For example, removal of the FcR from the lipid bilayer or from other 
accessory component(s) (e.g., specific phospholipids, glycolipids, or other membrane 
proteins) in the plasma membrane could cause a conformational change in the active 
site of the FcR. Similarly, the tendency of the receptor to form aggregates or protein 
micelles in aqueous solution, behavior previously reported for other integral  mem- 
brane proteins (38), might result in altered affinities for all IgG subclasses. For both 
aeetylcholine receptor (39), and IgE FoR (40), the solubilized proteins show greatly 
increased affinity and somewhat altered specificity relative to the membrane-associ- 
ated  molecule.  Alternatively,  it  is  possible  that  both  the  IgG2b-  and  the  IgG2a- 
binding sites are present on the same molecule. In this instance, the 2.4432 antigenic 
determinant  would  have to be close to the  IgG2b site,  with  the  15%  inhibition  of 
IgG2a  binding  by  2.4G2  Fab consistent  with  a  small  degree of steric hinderance. 
However, it is clear from the quantitative binding data on intact cells that there are 
many more binding sites for the 2.4G2 Fab than for IgG2a on both thioglycollate- 
elicited macrophages and the RAW 309 Cr. 1 line. Therefore, any proposal that the 
2.4G2 antigen is a component of the trypsin-sensitive IgG2a FcR will have to account 
for that  disparity.  Possibilities  under consideration  are:  (a)  the  IgG2a  FcR  site  is 
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membrane  protein(s)  present  in  smaller amounts, and  that  these  associations arc 
abolished (or the accessory proteins degraded) when the cells are treated with trypsin. 
In this regard, it is interesting to note that Anderson and Grey (41) have reported 
that crude lysates of the P388D1 macrophage line from which detergent was removed 
by SM-2 BioBeads had two activities separable by velocity sedimentation. Material 
capable of binding IgG aggregates (but not IgG2a) was found to sediment at >19S, 
whereas material sedimenting at 4-5S could bind IgG2a. The IgG aggregate activity 
was phospholipase (] sensitive, in contrast to the present results with a highly purified 
FcR preparation. They also observed that the T cell line $49.1, which we found bears 
the 2.4432 antigen, did not have IgG2a binding activity. We are at present isolating 
the $49.1  receptor to examine its subclass specificity. 
2.4G2 Fab was also employed to investigate the structure of the FcR expressed by 
several other macrophage and lymphoid cell lines and cell types. As shown in Fig. 1, 
a  significant degree of heterogeneity was observed. After SDS-PAGE, diffuse radio- 
active bands were found that ranged from 47,000 Mr (thioglycollate-elicited peritoneal 
macrophages) to >70,000 Mr (the B lymphocyte cell line WEHI-231). Each of these 
molecules bears the common 2.4G2 antigenic determinant, and, moreover, the FcR 
activity of each cell type was blocked by prior incubation with 2.4G2 (9). Although 
we do not know the reason for these differences in Mr of FcR, there is some precedent 
for  such  heterogeneity of antigens  isolated  from  different cell  types  by  use  of a 
monoclonal antibody. For example the rat leukocyte common antigen recognized by 
MR(]  OX-I  immunoprecipitates  polypeptides  of  150,000  Mr  from  thymocytes, 
170,000  Mr  from T  lymphocytes, 200,000  Mr  from  B  lymphocytes, and  130,000- 
150,000 from bone marrow cells (42). 
One  possible  source  of the  observed  heterogeneity in  Mr  of FcR  isolated  from 
different sources could be differences in glycosylation. Alternatively, such heteroge- 
neity might reflect differing levels of proteases secreted by the ceils. Trypsin digestion 
of intact cells does not inactivate FcR activity for IgG2b or rabbit immune complexes 
(7), nor does it destroy the 2.4G2 antigenic site. However, trypsinization did decrease 
the Mr of the J774 FcR (Fig. 2) apparently by converting the 60,000-Mr polypeptide 
to  one  similar  in  size  to  the  smaller  47,000-Mr  component.  Consistent  with  the 
possibility that FcR may be self-digested in this way, is that thioglycollate-elicited 
macrophages, which release neutral proteases (43), had the lowest Mr FcR of all cell 
types  examined.  Whatever  the  source  of the  observed  size  heterogeneity  among 
different FcR,  it  is  nonetheless  interesting  that  a  monoclonal  anti-FcR  antibody 
originally raised against the receptor expressed by the macrophage cell lines J774 and 
P388D1 can recognize FcR expressed by cells of greatly divergent lineages. 
Although previous  estimates of FcR  Mr  have spanned  a  wide range  (<20,000- 
255,000),  there have been  several  reports  which agree fairly well with our results. 
Loube et al. (10) isolated a 57,000-Mr  protein of broad electrophoretic mobility from 
the P388D1  macrophage line; (]unningham-Rundles et al.  (11) reported a  trypsin- 
resistant FcR from human peripheral mononuclear cells of 60,000 Mr; Kulczycki et 
al. (12) reported isolation of a receptor from rabbit alveolar macrophages of ~50,000 
Mr. 
However, the approach we have employed to isolate FcR is substantially different 
from such previous attempts. Earlier efforts have relied on affinity chromatography 
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the estimation of yields or recoveries, and the only control possible for specificity was 
to compare species  recovered  from control  adsorbents coated with Fab  or F(ab')2 
fragments. In addition, in most cases, only trace amounts of material were isolated, 
labeled isotopically with either 125I after cell surface iodination, or labeled biosyn- 
thetically after incorporation of oligosaccharide precursors. Hence, contamination by 
cytoplasmic proteins such as actin (which has considerable affinity for IgG [44]) could 
not be assessed. 
The only previous study in which activity of the isolated material was reported by 
Kulczycki et al.  (12),  who isolated 125I- or [14C]glucosamine-labeled molecules from 
NP40  lysates  of rabbit  alveolar  macrophages.  After  elution  from  IgG-Sepharose 
columns with 0.5 M  acetic acid, the adsorbed material had a broad -50,000 Mr and 
was capable of rebinding to IgG-Sepharose, a result that is agreement with our results. 
It should be emphasized that we have relied solely on the antigenicity of the FcR 
recognized by the anti-FcR antibody, to purify the receptor from cell lysates, and that 
the capability of the isolated protein to bind to IgG in an acid-labile fashion thus 
represented  a  completely independent  property  of the  molecule.  In  addition, our 
preliminary results  indicate that  a  rabbit  antiserum prepared  against  the  isolated 
antigen also specifically inhibits FoR activity of mouse macrophages and immuno- 
precipitates identical polypeptides. 
The  availability  of pure  Fc  receptor  will  make  possible  structural  studies  of 
functional  domains  of the  receptor  after  proteolytic cleavage,  and  reconstitution 
experiments to study the effect of insertion into a lipid bilayer on subclass specificity. 
Comparison of the detailed structure of this  FcR with the IgE FcR, which seems 
quite comparable in its acid lability and Mr (45), may demonstrate the presence of a 
family of receptors with closely related structures but with exquisitely defined speci- 
ficities. 
Summary 
We recently reported the isolation of a rat monoclonal antibody designated 2.4G2 
(9)  that is directed against the mouse trypsin-resistant Fc receptor (FcR)  for IgG2b 
and IgG1 immune aggregates. We have now utilized the Fab fragment of 2.4G2 as an 
affinity reagent  to  purify  FcR  from  the  macrophage  cell  line J774  to  apparent 
homogeneity. The antigen isolated from J774 cells consisted of two general types of 
polypeptides with broad electrophoretic mobilities of ~60,000  and 47,000  mol wt. 
Similar broad bands ranging from 47,000 to 70,000 mol wt were isolated from various 
FcR-bearing cell lines of B, T, and null lymphocyte, as well as of macrophage origin. 
.1774 FcR was judged to be a  glycoprotein based on the sensitivity of its isoelectric 
point to neuraminidase digestion, its labeling with galactose oxidase/NaB[3H4], and 
its binding to concanavalin A-Sepharose. In phosphate-buffered saline, the isolated 
protein formed large aggregates that were shown to retain FeR activity, albeit with 
a somewhat altered IgG subclass specificity. The FcR agglutinated erythrocytes that 
were coated with both IgG2b and IgG2a that did not otherwise hemagglutinate. In 
addition, iodinated FoR bound to Sephadex beads coated with rabbit  IgG, mouse 
IgG1, IgG2b, and IgG2a, but not to beads coated with mouse IgG3 or rabbit F(ab')2 
fragments. The binding of the purified receptor to all IgG classes was inhibited by the 
Fab fragments of 2.4G2. In contrast, the binding of IgG2a to intact macrophages was IRA S.  MELLMAN AND JAY C.  UNKELESS  1067 
inhibited by 2.4G2 Fab by only 15%, whereas rabbit IgG immune aggregate binding 
was almost completely abolished. 
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